-

Pharma Veteran, Academician and Researcher Cristina Masseria, PhD, MSc to be Head of the Value and Evidence Team at AESARA

CHAPEL HILL, N.C. & TORONTO & LONDON--(BUSINESS WIRE)--AESARA welcomes Cristina Masseria to AESARA bringing over 20 years of experience that spans across multiple therapy areas, research methods, innovation, and corporate leadership further expanding AESARA’s growth.

Sissi Pham, CEO of AESARA, said, "Cristina brings a depth of academic training and industry Market Access and Health Economics and Outcomes Research (HEOR) expertise. The unique combination of expertise and her proven ability to build and manage a high powered technical team will be invaluable as Cristina leads the expansion of the Value and Evidence team.”

Cristina began her research fellowship at Erasmus University and continued with the fellowship and lectureship at the London School of Economics. She then had a high trajectory career in the pharmaceutical industry culminating with the VP for Access and HEOR at Pfizer where she led the pricing and access strategy for the COVID-19 vaccine and treatment. “Consulting seems to be a natural extension of my professional career after experience in academia and industry. I am very excited to join AESARA’s team of talented leaders and experts, and help them to continue to grow as a trusted partner in demonstrating the value of innovative medicines, vaccines, and medical devices,” said Cristina Masseria.

Ruslan Horblyuk, Chief Strategic Consulting Officer, added, “AESARA’s focus on growing the Value and Evidence team and sharpening its methodological acumen is very much aligned with Cristina’s career aspirations to build a world-class digital-forward Market Access and HEOR Agency. I am thrilled to welcome Cristina to AESARA and look forward to working alongside and learning from her.”

About AESARA

AESARA is a market access agency with a focused purpose to impact healthcare decision-making to improve people’s lives. Established in 2016, we are a woman and minority-owned company with biopharma seasoned industry professionals in the U.S., Canada, and Europe. Our diverse team is passionate about delivering to our client’s transformative market access strategies and innovative digital communication solutions. For more information, please visit www.aesara.com and connect with AESARA on Twitter and LinkedIn.

Contacts

Pam Read
+1 587 233 4260 / pam@aesara.com

AESARA, Inc.


Release Versions

Contacts

Pam Read
+1 587 233 4260 / pam@aesara.com

More News From AESARA, Inc.

AESARA Announces Appointment of Jennifer Cain Birkmose as Vice President, Strategic Partnerships, Europe

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--AESARA, a leading digital-forward Value & Access agency, today announced the appointment of Jennifer Cain Birkmose as VP, Strategic Partnerships, Europe. With over 20 years of experience spanning healthcare, biotechnology, and pharmaceuticals, Jennifer brings deep expertise in innovative access strategies, global health partnerships, and policy leadership that will strengthen AESARA’s mission to advance value-driven a...

AESARA Welcomes Industry Veteran Anita Brogan as VP of Modeling and Communications

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--AESARA, a leading digital-forward Value & Access agency, today announced the appointment of Anita Brogan, PhD, as Vice President, Value & Evidence - Modeling and Communications within its Value and Evidence team. With over 20 years of experience designing and building economic analyses to support value assessment and patient access for innovative healthcare interventions, Anita brings deep expertise in both global...

AESARA Strengthens its Market Access Leadership with Key Executive Appointment of Amy Winnen as Vice President, Strategic Partnerships

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland--(BUSINESS WIRE)--AESARA, a digital-first Value & Access agency, has appointed Amy Winnen as Vice President, Strategic Partnerships. With over 25 years of experience in the biotechnology and pharmaceutical industries, Amy has helped emerging companies bring new therapies to market and improve patient access. "We are thrilled to welcome Amy to our team," said Chad Patel, Head of US Strategic Partnerships at AESARA. "Her deep expertise i...
Back to Newsroom